CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

SBI Healthcare Opp Fund-Reg(G)

very highequitypharma & health care
393.15 -4.11(-1.03%) NAV as on 10 Mar 2025
-5.79 % 1 M
16.42 % 1 Y
22.32 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.95

As on 28 Feb, 2025
age-icon Age :

25 yrs 7 m

Since 14 07 ,1999
exit_load Exit Load :

0.5%

aum AUM :

3,312.89 Crs

lock_in Lock-in :

0.50% on or before 15D, Nil after 15D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.17

Min_Investment Min. Investment :

SIP 500 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Tanmaya Desai,Pradeep Kesavan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 28 ,2025
Debt 0.09 %
Others 2.62 %
Equity 97.29 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.47 %
Max Healthcare Institute Ltd.6.50 %
Divi's Laboratories Ltd.6.20 %
Cipla Ltd.5.10 %
Lonza Group Ag5.00 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs62.18
Hospital & Healthcare Services23.18
Chemicals3.61
Medical Equipment/Supplies/Accessories3.32
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 07-Mar-2025)252.90286.90281.32444.33514.58
Net Assets(Rs Crores) (as on 07-Mar-2025) 1563.95 1778.29 1589.27 2626.34 3312.89
Scheme Returns(%)(Absolute)73.5112.48-1.8658.8814.78
B'mark Returns(%)(Absolute)NANANANANA
Category Rank39/7548/7557/7614/904/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

SBI Healthcare Opp Fund-Reg(G)Very HighEquity393.15-4.11(-1.03%)NAV As on 11 Mar, 202514-Jul-1999Inception Date3,312.89AUM In Cr.16.42%1Y22.32%3Y25.80%5Y16.11%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity34.890.03(0.09%)NAV As on 11 Mar, 202513-Jul-2018Inception Date4,611.47AUM In Cr.15.45%1Y21.88%3Y27.40%5Y20.62%Since Inception
Nippon India Pharma Fund(G)Very HighEquity465.31-2.67(-0.57%)NAV As on 11 Mar, 202505-Jun-2004Inception Date7,637.04AUM In Cr.8.62%1Y18.26%3Y24.61%5Y20.30%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity27.32-0.23(-0.84%)NAV As on 11 Mar, 202528-Dec-2015Inception Date1,103.99AUM In Cr.8.84%1Y18.04%3Y23.10%5Y11.53%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.